Comparative Analysis of Profitability Performance in the Pharmaceutical Industry of Bangladesh: Pre and Post COVID-19

Abstract

Covid-19 was emerged as pandemic in the entire world during 2020 and 2021 causing death of huge number of life in the globe. Bangladesh was not an exception. Being a life-threatening disease, it has great impact on the pharmaceutical companies of any country. The study was aimed to find any difference in performance of some selected pharmaceutical companies due to Covid-19 pandemic. The medicine and vaccine related with Covid-19 was in peak of demand that caused to increase the profitability of the companies. However, the normal and avoidable treatments were deliberately delayed during the period. The study finds no significant difference in the performance of pharmaceutical companies during the pandemic and after the pandemic.